Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 435.00
DYII's Cash to Debt is ranked lower than
99.99% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 0.29 vs. DYII: 435.00 )
Ranked among companies with meaningful Cash to Debt only.
DYII' s Cash to Debt Range Over the Past 10 Years
Min: 0.25  Med: 10.14 Max: No Debt
Current: 435
Equity to Asset 0.49
DYII's Equity to Asset is ranked lower than
99.99% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. DYII: 0.49 )
Ranked among companies with meaningful Equity to Asset only.
DYII' s Equity to Asset Range Over the Past 10 Years
Min: 0.49  Med: 0.70 Max: 0.89
Current: 0.49
0.49
0.89
F-Score: 2
Z-Score: -0.32
M-Score: -3.04
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -130.80
DYII's Operating margin (%) is ranked lower than
99.99% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 7.46 vs. DYII: -130.80 )
Ranked among companies with meaningful Operating margin (%) only.
DYII' s Operating margin (%) Range Over the Past 10 Years
Min: -491.12  Med: -63.61 Max: 992.41
Current: -130.8
-491.12
992.41
Net-margin (%) -87.28
DYII's Net-margin (%) is ranked lower than
99.99% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 4.28 vs. DYII: -87.28 )
Ranked among companies with meaningful Net-margin (%) only.
DYII' s Net-margin (%) Range Over the Past 10 Years
Min: -219.69  Med: -29.87 Max: 1063.02
Current: -87.28
-219.69
1063.02
ROE (%) -23.96
DYII's ROE (%) is ranked lower than
99.99% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 9.24 vs. DYII: -23.96 )
Ranked among companies with meaningful ROE (%) only.
DYII' s ROE (%) Range Over the Past 10 Years
Min: -40.22  Med: -11.43 Max: 13.38
Current: -23.96
-40.22
13.38
ROA (%) -12.88
DYII's ROA (%) is ranked lower than
99.99% of the 222 Companies
in the Global Medical Care industry.

( Industry Median: 3.42 vs. DYII: -12.88 )
Ranked among companies with meaningful ROA (%) only.
DYII' s ROA (%) Range Over the Past 10 Years
Min: -29.81  Med: -8.38 Max: 10.48
Current: -12.88
-29.81
10.48
ROC (Joel Greenblatt) (%) -73.53
DYII's ROC (Joel Greenblatt) (%) is ranked lower than
99.99% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 19.71 vs. DYII: -73.53 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
DYII' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -147.09  Med: -45.39 Max: 36.88
Current: -73.53
-147.09
36.88
Revenue Growth (3Y)(%) 10.30
DYII's Revenue Growth (3Y)(%) is ranked lower than
99.99% of the 160 Companies
in the Global Medical Care industry.

( Industry Median: 8.20 vs. DYII: 10.30 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
DYII' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -61.2  Med: 9.30 Max: 66.3
Current: 10.3
-61.2
66.3
EBITDA Growth (3Y)(%) -15.90
DYII's EBITDA Growth (3Y)(%) is ranked lower than
99.99% of the 128 Companies
in the Global Medical Care industry.

( Industry Median: 7.90 vs. DYII: -15.90 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
DYII' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -58.5  Med: 45.20 Max: 136.6
Current: -15.9
-58.5
136.6
EPS Growth (3Y)(%) -27.40
DYII's EPS Growth (3Y)(%) is ranked lower than
99.99% of the 121 Companies
in the Global Medical Care industry.

( Industry Median: 9.00 vs. DYII: -27.40 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
DYII' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -40  Med: 25.40 Max: 95.7
Current: -27.4
-40
95.7
» DYII's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with DYII

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 0.08
DYII's P/B is ranked lower than
100% of the 307 Companies
in the Global Medical Care industry.

( Industry Median: 2.47 vs. DYII: 0.08 )
Ranked among companies with meaningful P/B only.
DYII' s P/B Range Over the Past 10 Years
Min: 0.01  Med: 0.50 Max: 2.26
Current: 0.08
0.01
2.26
P/S 0.24
DYII's P/S is ranked lower than
99.99% of the 306 Companies
in the Global Medical Care industry.

( Industry Median: 1.25 vs. DYII: 0.24 )
Ranked among companies with meaningful P/S only.
DYII' s P/S Range Over the Past 10 Years
Min: 0.01  Med: 1.32 Max: 36.27
Current: 0.24
0.01
36.27
EV-to-EBIT 2.90
DYII's EV-to-EBIT is ranked lower than
99.99% of the 286 Companies
in the Global Medical Care industry.

( Industry Median: 17.96 vs. DYII: 2.90 )
Ranked among companies with meaningful EV-to-EBIT only.
DYII' s EV-to-EBIT Range Over the Past 10 Years
Min: -65  Med: 0.60 Max: 126.1
Current: 2.9
-65
126.1
EV-to-EBITDA 3.15
DYII's EV-to-EBITDA is ranked lower than
99.99% of the 300 Companies
in the Global Medical Care industry.

( Industry Median: 13.84 vs. DYII: 3.15 )
Ranked among companies with meaningful EV-to-EBITDA only.
DYII' s EV-to-EBITDA Range Over the Past 10 Years
Min: -35.9  Med: 3.10 Max: 91.2
Current: 3.15
-35.9
91.2
Current Ratio 0.92
DYII's Current Ratio is ranked lower than
99.99% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 1.33 vs. DYII: 0.92 )
Ranked among companies with meaningful Current Ratio only.
DYII' s Current Ratio Range Over the Past 10 Years
Min: 0.89  Med: 2.02 Max: 12.77
Current: 0.92
0.89
12.77
Quick Ratio 0.91
DYII's Quick Ratio is ranked lower than
99.99% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 1.22 vs. DYII: 0.91 )
Ranked among companies with meaningful Quick Ratio only.
DYII' s Quick Ratio Range Over the Past 10 Years
Min: 0.87  Med: 1.90 Max: 12.56
Current: 0.91
0.87
12.56
Days Inventory 63.12
DYII's Days Inventory is ranked lower than
99.99% of the 158 Companies
in the Global Medical Care industry.

( Industry Median: 16.82 vs. DYII: 63.12 )
Ranked among companies with meaningful Days Inventory only.
DYII' s Days Inventory Range Over the Past 10 Years
Min: 10.31  Med: 44.06 Max: 112.33
Current: 63.12
10.31
112.33
Days Sales Outstanding 59.62
DYII's Days Sales Outstanding is ranked lower than
99.99% of the 188 Companies
in the Global Medical Care industry.

( Industry Median: 46.01 vs. DYII: 59.62 )
Ranked among companies with meaningful Days Sales Outstanding only.
DYII' s Days Sales Outstanding Range Over the Past 10 Years
Min: 52.66  Med: 84.60 Max: 1478.93
Current: 59.62
52.66
1478.93
Days Payable 228.25
DYII's Days Payable is ranked lower than
99.99% of the 146 Companies
in the Global Medical Care industry.

( Industry Median: 42.47 vs. DYII: 228.25 )
Ranked among companies with meaningful Days Payable only.
DYII' s Days Payable Range Over the Past 10 Years
Min: 44.81  Med: 140.39 Max: 532.04
Current: 228.25
44.81
532.04

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 0.08
DYII's Price/Tangible Book is ranked lower than
99.99% of the 201 Companies
in the Global Medical Care industry.

( Industry Median: 3.44 vs. DYII: 0.08 )
Ranked among companies with meaningful Price/Tangible Book only.
DYII' s Price/Tangible Book Range Over the Past 10 Years
Min: 0.01  Med: 1.15 Max: 10.7
Current: 0.08
0.01
10.7
Price/Median PS Value 0.18
DYII's Price/Median PS Value is ranked lower than
99.99% of the 285 Companies
in the Global Medical Care industry.

( Industry Median: 1.01 vs. DYII: 0.18 )
Ranked among companies with meaningful Price/Median PS Value only.
DYII' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.01  Med: 1.07 Max: 22.8
Current: 0.18
0.01
22.8
Earnings Yield (Greenblatt) (%) 34.50
DYII's Earnings Yield (Greenblatt) (%) is ranked lower than
99.99% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 4.40 vs. DYII: 34.50 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
DYII' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.8  Med: 29.90 Max: 6686.1
Current: 34.5
0.8
6686.1
Forward Rate of Return (Yacktman) (%) 224.71
DYII's Forward Rate of Return (Yacktman) (%) is ranked lower than
99.99% of the 101 Companies
in the Global Medical Care industry.

( Industry Median: 10.86 vs. DYII: 224.71 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
DYII' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -2889.5  Med: 6.10 Max: 50.5
Current: 224.71
-2889.5
50.5

More Statistics

Revenue(Mil) $6
EPS $ -0.36
Beta-0.98
Short Percentage of Float0.84%
52-Week Range $0.08 - 0.80
Shares Outstanding(Mil)13.60

Business Description

Industry: Health Care Providers » Medical Care
Compare: » details
Dynacq Healthcare Inc was incorporated in Nevada in February 1992. The Company was reincorporated in Delaware in November 2003 and reincorporated back in Nevada in August 2007. The Company is a holding company that through its subsidiaries in the United States develops and manages general acute care hospitals that principally provide specialized surgeries. The Company through its United States subsidiaries owns and operates one general acute care hospital in Pasadena, Texas. The Company through its subsidiary in Hong Kong invests in debt and equity securities, including short-term investments in initial public offerings and pre-initial public offerings. The Company's hospital, Surgery Specialty Hospitals of America - Southeast Houston Campus in Pasadena, Texas, near Houston (the Pasadena facility), includes operating rooms, pre- and post-operative space, intensive care units, nursing units and diagnostic facilities, as well as adjacent medical office buildings. The Company operates in the greater Houston, Texas market. In the United States, the Company manages and operates one general acute care hospital that principally provides specialized surgeries such as bariatric, orthopedic and neuro-spine surgeries. The Company competes with other providers, including major acute care hospitals. It also encounters competition with other companies for strategic relationships with physicians. The Company complies with government regulation at the federal, state and local levels.

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK